骆嵩, 李理, 刘东亮, 屈洪党. miR-34c抑制NLRP3炎性小体诱导的小胶质细胞焦亡机制研究[J]. 蚌埠医科大学学报, 2023, 48(5): 561-564. DOI: 10.13898/j.cnki.issn.1000-2200.2023.05.001
    引用本文: 骆嵩, 李理, 刘东亮, 屈洪党. miR-34c抑制NLRP3炎性小体诱导的小胶质细胞焦亡机制研究[J]. 蚌埠医科大学学报, 2023, 48(5): 561-564. DOI: 10.13898/j.cnki.issn.1000-2200.2023.05.001
    LUO Song, LI Li, LIU Dong-liang, QU Hong-dang. Study on the mechanism of miR-34c inhibiting NLRP3 inflammasome-induced microglia pyrolysis[J]. Journal of Bengbu Medical University, 2023, 48(5): 561-564. DOI: 10.13898/j.cnki.issn.1000-2200.2023.05.001
    Citation: LUO Song, LI Li, LIU Dong-liang, QU Hong-dang. Study on the mechanism of miR-34c inhibiting NLRP3 inflammasome-induced microglia pyrolysis[J]. Journal of Bengbu Medical University, 2023, 48(5): 561-564. DOI: 10.13898/j.cnki.issn.1000-2200.2023.05.001

    miR-34c抑制NLRP3炎性小体诱导的小胶质细胞焦亡机制研究

    Study on the mechanism of miR-34c inhibiting NLRP3 inflammasome-induced microglia pyrolysis

    • 摘要:
      目的探索miR-34c在调控NLRP3炎性小体激活caspase-1信号通路诱导小胶质细胞焦亡中的作用。
      方法观察脂多糖(LPS)联合ATP激活小胶质细胞后,通过乳酸脱氢酶(LDH)细胞毒性检测试剂盒检测LDH的释放,以判断小胶质细胞细胞膜的完整性;再对miR-34c转染后的小胶质细胞在LPS和ATP激活下,观察小胶质细胞细胞膜变化。采用细胞增殖毒性检测试剂盒(CCK-8)分别检测miR-34c转染后的小胶质细胞和未转染的小胶质细胞在LPS和ATP刺激下活力变化情况。采用蛋白免疫印迹分别检测LPS+ATP诱导的小胶质细胞(对照组)中和miR-34c转染后小胶质细胞(观察组)中的蛋白表达情况,如NLRP3炎性小体、caspase-1、GSDMD、IL-1β、IL-18。
      结果LPS+ATP联合诱导下的小胶质细胞较正常的小胶质细胞,miR-34c表达减少(P < 0.01);观察组小胶质细胞LDH释放水平较对照组下降(P < 0.01);CCK-8测试细胞活力中,2组小胶质细胞除第1天活力差异无统计学意义(P>0.05)外,其他时间观察组均明显高于对照组(P < 0.01);观察组中小胶质细胞中NLRP3炎性小体、caspase-1、GSDMD、IL-1β、IL-18生成较之对照组小胶质细胞中炎性小体相关因子减少(P < 0.01)。
      结论miR-34c可以抑制LPS+ATP诱导的小胶质细胞焦亡,可能通过降低NLRP3炎性小体活化及下游caspase-1依赖细胞焦亡信号通路关键蛋白表达有关。

       

      Abstract:
      ObjectiveTo explore the role of miR-34c in regulating NLRP3 inflammasome to activate the caspase-1 signaling pathway to induce microglia pyrolysis.
      MethodsAfter the observation of lipopolysaccharide (LPS) combined with ATP for activating microglia, the release of lactate dehydrogenase (LDH) was detected using LDH cytotoxicity detection kit to determine the integrity of the microglia cell membrane; then, the microglia transfected with miR-34c are activated by LPS and ATP, which was observed for the changes in glial cell membrane; cell proliferation and toxicity detection kit (CCK-8) was used to detect changes in the viability of miR-34c transfected microglia and untransfected microglia under the stimulation of LPS and ATP; Western blotting was used to detect the protein expression in LPS+ATP-induced microglia and microglia after miR-34c transfection, such as NLRP3 inflammasome, caspase-1, GSDMD, IL-1β, IL-18.
      ResultsCompared with normal microglia, the expression of miR-34c in microglia induced by LPS+ATP combination decreased (P < 0.01);the LDH release level of microglia in the observation group was lower than that in the control group (P < 0.01);in the CCK-8 cell viability test, there was no significant difference of the microglia viability between the two groups on the first day(P>0.05), while the observation group was significantly higher than the control group at other times (P < 0.01);the production of NLRP3 inflammasome, caspase-1, GSDMD, IL-1β and IL-18 of microglia in the observation group was decreased compared with those in the control group (P < 0.01).
      ConclusionsMiR-34c can inhibit LPS+ATP-induced microglial pyroptosis, which may be related to the reduction of NLRP3 inflammasome activation and key proteins expression in the downstream caspase-1-dependent pyroptosis signaling pathway.

       

    /

    返回文章
    返回